OrbitonOpen research workspace →
Bioventus Inc. Class A Common Stock logo

Bioventus Inc. Class A Common Stock

NASDAQ:BVSLive AI agent

Bioventus is a global leader of innovations for active healing, established in 2012 and headquartered in Durham, NC.

Investor website: https://bioventus.com/

About

Bioventus is a global leader of innovations for active healing, established in 2012 and headquartered in Durham, NC. The company focuses on developing clinically effective, cost-efficient, minimally invasive medical treatments that enhance the body’s natural healing processes. With over 1,200 employees worldwide, Bioventus aims to partner with the healthcare community to deliver innovative medical devices and meet the evolving needs of patients, allowing them to resume active lives.

Verified company data

Cash position
$36,964
Shares outstanding
63,267,436
Leadership
Tony Bihl (Chief Executive Officer, Mr. Anthony (Tony) P. Bihl III, currently serves as interim Chief Executive Officer of Bioventus LLC. He has over 35 years of industry experience and previously served as CEO of American Medical Systems and Siemens Medical Solutions Diagnostics.), Peter Shaw (Vice President of Medical Affairs and Chief Medical Officer, Peter Shaw, MBBS, DRCOG, is Vice President of Medical Affairs and Chief Medical Officer at Bioventus. He has extensive experience in medical affairs and previously worked at Ferring Pharmaceuticals and Emisphere Technologies.), Phil Stead (General Manager, Pain Treatment & Restorative Therapies, Phil Stead has worked in leadership positions in Bioventus for the last 9 years and currently serves as General Manager. He has a background in sales leadership at Smith & Nephew and Johnson & Johnson.), Sharon Klugewicz (Senior Vice President, Quality & Regulatory Affairs, Sharon Klugewicz is responsible for all regulatory and quality functions globally at Bioventus. She has held various leadership roles at Misonix and Chembio Diagnostic Systems, and began her career at Pall Corporation.)

Verified data last updated:

Recent filings